LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 97 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64 | -12.3% | 54,482 | +5.8% | 0.00% | – |
| Q2 2023 | $73 | +1.4% | 51,482 | +6.2% | 0.00% | – |
| Q1 2023 | $72 | +26.3% | 48,489 | -1.0% | 0.00% | – |
| Q4 2022 | $57 | -99.9% | 48,989 | +14.0% | 0.00% | – |
| Q3 2022 | $48,000 | -32.4% | 42,990 | -5.5% | 0.00% | – |
| Q2 2022 | $71,000 | +1.4% | 45,490 | +0.0% | 0.00% | – |
| Q1 2022 | $70,000 | -25.5% | 45,489 | +17.8% | 0.00% | – |
| Q4 2021 | $94,000 | -14.5% | 38,629 | -12.1% | 0.00% | – |
| Q3 2021 | $110,000 | -28.6% | 43,939 | -19.1% | 0.00% | – |
| Q2 2021 | $154,000 | +36.3% | 54,339 | +12.4% | 0.00% | – |
| Q1 2021 | $113,000 | -28.5% | 48,325 | -46.2% | 0.00% | – |
| Q4 2020 | $158,000 | +85.9% | 89,829 | -1.7% | 0.00% | – |
| Q3 2020 | $85,000 | +14.9% | 91,419 | +7.0% | 0.00% | – |
| Q2 2020 | $74,000 | +21.3% | 85,419 | +14.2% | 0.00% | – |
| Q1 2020 | $61,000 | +3.4% | 74,828 | +11.7% | 0.00% | – |
| Q4 2019 | $59,000 | -47.3% | 67,010 | -41.4% | 0.00% | – |
| Q3 2019 | $112,000 | – | 114,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $28,160,000 | 3.29% |
| Defender Capital, LLC. | 4,416,590 | $3,657,000 | 2.67% |
| Prescott General Partners LLC | 1,851,851 | $1,534,000 | 0.13% |
| Laidlaw Wealth Management LLC | 107,379 | $89,000 | 0.06% |
| Northeast Financial Consultants Inc | 523,756 | $434,000 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $37,000 | 0.04% |
| DAFNA Capital Management LLC | 95,000 | $79,000 | 0.03% |
| Summit X, LLC | 30,700 | $25,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 529,039 | $438,000 | 0.01% |
| Keudell/Morrison Wealth Management | 10,105 | $8,000 | 0.01% |